AKT1 and cancer: Using the HCC1937 PTEN-null cancer cell line, Gulati et al. observed that 25 μM quercetin may decrease active AKT/PKB phosphorylation and dramatically limit cell proliferation of PTEN-null cancer cells, which is consistent with previous studies [43].